Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Moleculin Biotech, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +4 vs. Q2 2024
- Shares held
- 460.6K
- +159.3K (+52.9%) vs. Q2 2024
- Total value
- $1.31M
- +$248.2K (+23.4%) vs. Q2 2024
- New holders
- 4
- 5 more added
- Sold out
- 0
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 290,000 | $823.6K | 0.02% | +134,000+85.9% | Added |
| Vanguard Group Inc | 71,403 | $202.8K | 0.00% | −13,015−15.4% | Reduced |
| LPL Financial LLC | 36,103 | $102.5K | 0.00% | +2,349+7.0% | Added |
| Geode Capital Management, LLC | 21,818 | $62.0K | 0.00% | +2,062+10.4% | Added |
| BlackRock, Inc. | 12,475 | $35.4K | 0.00% | +12,475 | New |
| Renaissance Technologies LLC | 10,996 | $31.2K | 0.00% | +10,996 | New |
| Truist Financial Corp | 10,500 | $29.8K | 0.00% | +10,500 | New |
| Atticus Wealth Management, LLC | 3,334 | $9.47K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,811 | $5.14K | 0.00% | −184−9.2% | Reduced |
| Newbridge Financial Services Group, Inc. | 1,367 | $3.88K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 449 | $1.27K | 0.00% | +23+5.4% | Added |
| Bank of America Corp | 143 | $406 | 0.00% | +115+410.7% | Added |
| Sandy Spring Bank | 89 | $253 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 34 | $97 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 23 | $65 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 17 | $48 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $6 | 0.00% | +2 | New |
| JPMorgan Chase & Co | 1 | $3 | 0.00% | −5−83.3% | Reduced |
| Royal Bank of Canada | 1 | $0 | 0.00% | −9−90.0% | Reduced |
| BlackRock Inc. | – | – | – | – | Not filed |